The majority of the primary tumours (67 of 73), the xenografts GB217X4 and GB166X1 and the cell line Tp265MG were examined by real-time PCR analysis confirming the P1- and P2-MDM2 usage (Table 1 and Supplementary Table 1). This evidence concerns the gene MDM2 and neoplasm.